Skip to main content
Springer Nature Link
Log in

Impact of serum vitamin D level on risk of bladder cancer: a systemic review and meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Vitamin D has important biological functions including modulation of the immune system and anti-cancer effects. There was no conclusive finding of the impact of serum vitamin D level on bladder cancer risk. A systemic review and meta-analysis was performed to assess the impact of serum 25-hydroxyvitamin D level on bladder cancer risk. The pooled relative risk (RR) with 95 % confidence interval (95%CI) was used to assess the impact of serum 25-hydroxyvitamin D level on bladder cancer risk. A total of 89,610 participants and 2238 bladder cancer cases were finally included into the meta-analysis. There was no obvious heterogeneity among those included studies (I 2 = 0 %). Meta-analysis total included studies which showed that a high serum 25-hydroxyvitamin D level could obviously decrease risk of bladder cancer (RR = 0.75, 95%CI 0.65–0.87, P < 0.001). In addition, the pooled RRs were not significantly changed by excluding any single study. The findings from the meta-analysis suggest an obvious protective effect of vitamin D against bladder cancer. Individuals with higher serum 25-hydroxyvitamin D levels suffer from less risk of subsequent bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. Apolo AB, Hoffman V, Kaag MG, Latini DM, Lee CT, Rosenberg JE, et al. Summary of the 8th annual bladder cancer think tank: collaborating to move research forward. Urol Oncol. 2014.

  2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.

    Article  PubMed  Google Scholar 

  3. Keimling M, Behrens G, Schmid D, Jochem C, Leitzmann MF. The association between physical activity and bladder cancer: systematic review and meta-analysis. Br J Cancer. 2014;110:1862–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC. Ultraviolet b irradiance and incidence rates of bladder cancer in 174 countries. Am J Prev Med. 2010;38:296–302.

    Article  PubMed  Google Scholar 

  5. Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374:239–49.

    Article  CAS  PubMed  Google Scholar 

  6. Albert PJ, Proal AD, Marshall TG. Vitamin D: the alternative hypothesis. Autoimmun Rev. 2009;8:639–44.

    Article  CAS  PubMed  Google Scholar 

  7. Dixon KM, Mason RS. Vitamin D. Int J Biochem Cell Biol. 2009;41:982–5.

    Article  CAS  PubMed  Google Scholar 

  8. Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010;9:941–55.

    Article  CAS  PubMed  Google Scholar 

  9. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008;8:685–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94:26–34.

    Article  CAS  PubMed  Google Scholar 

  11. Bischoff-Ferrari HA. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol. 2014;810:500–25.

    PubMed  Google Scholar 

  12. Ordonez Mena JM, Brenner H. Vitamin D and cancer: an overview on epidemiological studies. Adv Exp Med Biol. 2014;810:17–32.

    PubMed  Google Scholar 

  13. Lee JE, Li H, Chan AT, et al. Circulating levels of vitamin D and colon and rectal cancer: the physicians’ health study and a meta-analysis of prospective studies. Cancer Prev Res (Phila). 2011;4:735–43.

    Article  CAS  Google Scholar 

  14. Ordonez-Mena JM, Schottker B, Haug U, et al. Serum 25-hydroxyvitamin D and cancer risk in older adults: results from a large German prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2013;22:905–16.

    Article  CAS  PubMed  Google Scholar 

  15. Kim Y, Je Y. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Br J Cancer. 2014;110:2772–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98:451–9.

    Article  CAS  PubMed  Google Scholar 

  17. Amaral AF, Mendez-Pertuz M, Munoz A, et al. Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study. J Natl Cancer Inst. 2012;104:1897–904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Afzal S, Bojesen SE, Nordestgaard BG. Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. Clin Chem. 2013;59:771–80.

    Article  CAS  PubMed  Google Scholar 

  19. Mondul AM, Weinstein SJ, Horst RL, Purdue M, Albanes D. Serum vitamin D and risk of bladder cancer in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2012;21:1222–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Mondul AM, Weinstein SJ, Virtamo J, Albanes D. Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Br J Cancer. 2012;107:1589–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed  PubMed Central  Google Scholar 

  22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  23. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    CAS  PubMed  Google Scholar 

  24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med. 2007;26:4544–62.

    Article  PubMed  Google Scholar 

  26. Mondul AM, Weinstein SJ, Mannisto S, et al. Serum vitamin D and risk of bladder cancer. Cancer Res. 2010;70:9218–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Pommergaard HC, Burcharth J, Rosenberg J, Raskov H. Oral chemoprevention with acetyl salicylic acid, vitamin D and calcium reduces the risk of tobacco carcinogen-induced bladder tumors in mice. Cancer Invest. 2013;31:490–3.

    Article  CAS  PubMed  Google Scholar 

  28. Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol. 2011;51:311–36.

    Article  CAS  PubMed  Google Scholar 

  29. Chen P, Li M, Gu X, et al. Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case–control study and meta-analysis of the observational studies. PLoS One. 2013;8:e49312.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155:827–38.

    Article  PubMed  Google Scholar 

  31. Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014;2:307–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Urology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, No. 32, Section 2, West 1st Ring Road, Chengdu, 610072, China

    Yong Liao, Jian-Lin Huang, Ming-Xing Qiu & Zhi-Wei Ma

Authors
  1. Yong Liao
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Jian-Lin Huang
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Ming-Xing Qiu
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Zhi-Wei Ma
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Zhi-Wei Ma.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liao, Y., Huang, JL., Qiu, MX. et al. Impact of serum vitamin D level on risk of bladder cancer: a systemic review and meta-analysis. Tumor Biol. 36, 1567–1572 (2015). https://doi.org/10.1007/s13277-014-2728-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2728-9

Keywords